Editas Medicine, Inc.
EDIT
$1.33
-$0.21-13.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 32.31M | 61.76M | 67.03M | 69.41M | 78.12M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.31M | 61.76M | 67.03M | 69.41M | 78.12M |
| Cost of Revenue | 147.16M | 168.11M | 160.98M | 161.38M | 150.40M |
| Gross Profit | -114.85M | -106.35M | -93.95M | -91.97M | -72.27M |
| SG&A Expenses | 71.99M | 70.09M | 66.99M | 65.98M | 69.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 271.23M | 290.28M | 280.05M | 254.62M | 247.30M |
| Operating Income | -238.92M | -228.52M | -213.02M | -185.21M | -169.18M |
| Income Before Tax | -237.09M | -210.57M | -193.45M | -166.13M | -153.22M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -237.09 | -210.57 | -193.45 | -166.13 | -153.22 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -237.09M | -210.57M | -193.45M | -166.13M | -153.22M |
| EBIT | -238.92M | -228.52M | -213.02M | -185.21M | -169.18M |
| EBITDA | -233.11M | -222.63M | -207.21M | -179.28M | -163.12M |
| EPS Basic | -2.88 | -2.56 | -2.36 | -2.10 | -2.06 |
| Normalized Basic EPS | -1.71 | -1.59 | -1.46 | -1.30 | -1.27 |
| EPS Diluted | -2.88 | -2.56 | -2.36 | -2.10 | -2.06 |
| Normalized Diluted EPS | -1.71 | -1.59 | -1.46 | -1.30 | -1.27 |
| Average Basic Shares Outstanding | 329.35M | 328.44M | 327.61M | 316.67M | 303.66M |
| Average Diluted Shares Outstanding | 329.35M | 328.44M | 327.61M | 316.67M | 303.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |